CA3051807C - Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques - Google Patents
Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques Download PDFInfo
- Publication number
- CA3051807C CA3051807C CA3051807A CA3051807A CA3051807C CA 3051807 C CA3051807 C CA 3051807C CA 3051807 A CA3051807 A CA 3051807A CA 3051807 A CA3051807 A CA 3051807A CA 3051807 C CA3051807 C CA 3051807C
- Authority
- CA
- Canada
- Prior art keywords
- sample
- transplantation
- use according
- transplant
- hsc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1750629A FR3062063B1 (fr) | 2017-01-26 | 2017-01-26 | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
| FR1750629 | 2017-01-26 | ||
| PCT/EP2018/051941 WO2018138251A1 (fr) | 2017-01-26 | 2018-01-26 | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3051807A1 CA3051807A1 (fr) | 2018-08-02 |
| CA3051807C true CA3051807C (fr) | 2023-07-11 |
Family
ID=59325347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3051807A Active CA3051807C (fr) | 2017-01-26 | 2018-01-26 | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20200188450A1 (enExample) |
| EP (1) | EP3573631B1 (enExample) |
| JP (1) | JP7527109B2 (enExample) |
| KR (1) | KR102517287B1 (enExample) |
| CN (1) | CN110520141A (enExample) |
| AU (1) | AU2018212530B2 (enExample) |
| CA (1) | CA3051807C (enExample) |
| DK (1) | DK3573631T3 (enExample) |
| ES (1) | ES2937965T3 (enExample) |
| FI (1) | FI3573631T3 (enExample) |
| FR (1) | FR3062063B1 (enExample) |
| HR (1) | HRP20230122T1 (enExample) |
| HU (1) | HUE061155T2 (enExample) |
| IL (1) | IL268237B (enExample) |
| LT (1) | LT3573631T (enExample) |
| PL (1) | PL3573631T3 (enExample) |
| PT (1) | PT3573631T (enExample) |
| RS (1) | RS63978B1 (enExample) |
| SI (1) | SI3573631T1 (enExample) |
| WO (1) | WO2018138251A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3072032A1 (en) * | 2017-08-07 | 2019-02-14 | Finch Therapeutics, Inc. | Compositions and methods for maintaining and restoring a healthy gut barrier |
| US20220023419A1 (en) * | 2018-11-28 | 2022-01-27 | The Council Of The Queensland Institute Of Medical Research | Inhibiting inflammation |
| CN112375705A (zh) * | 2020-11-12 | 2021-02-19 | 安徽燕婉健康科技有限公司 | 一种替代天然菌群的肠壁移植优势菌的制备方法及其应用 |
| EP4386090A1 (en) * | 2022-12-12 | 2024-06-19 | Assistance Publique - Hôpitaux De Paris | Method for determining and improving the potential efficacy of anticancer treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2649719B1 (fr) * | 1989-07-17 | 1993-08-27 | Cerbio Sa | Procede de protection et de conservation de micro-organismes notamment de bacteries |
| CN103561752B (zh) * | 2011-03-09 | 2016-04-20 | 明尼苏达大学评议会 | 用于移植结肠微生物群的组合物和方法 |
| JP2016501852A (ja) * | 2012-11-26 | 2016-01-21 | トーマス・ジュリアス・ボロディ | 糞便微生物叢の回復のための組成物、ならびにそれらを作製および使用する方法 |
| US10046030B2 (en) * | 2014-10-07 | 2018-08-14 | University Of Virginia Patent Foundation | Compositions and methods for preventing and treating infection |
| AU2015353465B2 (en) * | 2014-11-25 | 2021-07-29 | Memorial Sloan-Kettering Cancer Center | Intestinal microbiota and GVHD |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| FR3035328B1 (fr) * | 2015-04-24 | 2019-08-23 | Maat Pharma | Procede de preparation d'un echantillon de microbiote fecal |
| JP6408092B2 (ja) * | 2016-08-29 | 2018-10-17 | 国立大学法人 東京大学 | 糞便微生物叢を含む組成物 |
-
2017
- 2017-01-26 FR FR1750629A patent/FR3062063B1/fr not_active Expired - Fee Related
-
2018
- 2018-01-26 WO PCT/EP2018/051941 patent/WO2018138251A1/fr not_active Ceased
- 2018-01-26 HU HUE18702952A patent/HUE061155T2/hu unknown
- 2018-01-26 US US16/480,863 patent/US20200188450A1/en not_active Abandoned
- 2018-01-26 LT LTEPPCT/EP2018/051941T patent/LT3573631T/lt unknown
- 2018-01-26 IL IL268237A patent/IL268237B/en unknown
- 2018-01-26 SI SI201830842T patent/SI3573631T1/sl unknown
- 2018-01-26 CN CN201880008477.0A patent/CN110520141A/zh active Pending
- 2018-01-26 CA CA3051807A patent/CA3051807C/fr active Active
- 2018-01-26 PT PT187029525T patent/PT3573631T/pt unknown
- 2018-01-26 KR KR1020197024970A patent/KR102517287B1/ko active Active
- 2018-01-26 RS RS20230101A patent/RS63978B1/sr unknown
- 2018-01-26 FI FIEP18702952.5T patent/FI3573631T3/fi active
- 2018-01-26 ES ES18702952T patent/ES2937965T3/es active Active
- 2018-01-26 JP JP2019540408A patent/JP7527109B2/ja active Active
- 2018-01-26 EP EP18702952.5A patent/EP3573631B1/fr active Active
- 2018-01-26 AU AU2018212530A patent/AU2018212530B2/en active Active
- 2018-01-26 DK DK18702952.5T patent/DK3573631T3/da active
- 2018-01-26 HR HRP20230122TT patent/HRP20230122T1/hr unknown
- 2018-01-26 PL PL18702952.5T patent/PL3573631T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3051807A1 (fr) | 2018-08-02 |
| LT3573631T (lt) | 2023-03-10 |
| FR3062063B1 (fr) | 2019-04-19 |
| SI3573631T1 (sl) | 2023-09-29 |
| DK3573631T3 (da) | 2023-01-30 |
| AU2018212530A1 (en) | 2019-09-05 |
| JP7527109B2 (ja) | 2024-08-02 |
| HUE061155T2 (hu) | 2023-05-28 |
| EP3573631B1 (fr) | 2022-11-16 |
| IL268237A (en) | 2019-09-26 |
| KR20190130563A (ko) | 2019-11-22 |
| PT3573631T (pt) | 2023-01-24 |
| ES2937965T3 (es) | 2023-04-03 |
| HRP20230122T1 (hr) | 2023-03-31 |
| JP2020506183A (ja) | 2020-02-27 |
| CN110520141A (zh) | 2019-11-29 |
| KR102517287B1 (ko) | 2023-03-31 |
| FI3573631T3 (fi) | 2023-03-02 |
| RS63978B1 (sr) | 2023-03-31 |
| WO2018138251A1 (fr) | 2018-08-02 |
| IL268237B (en) | 2022-07-01 |
| FR3062063A1 (fr) | 2018-07-27 |
| EP3573631A1 (fr) | 2019-12-04 |
| US20200188450A1 (en) | 2020-06-18 |
| PL3573631T3 (pl) | 2023-05-02 |
| AU2018212530B2 (en) | 2022-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6907288B2 (ja) | マイクロバイオータ回復治療（ｍｒｔ）組成物 | |
| EP3762001B1 (fr) | Procédure de collecte de selles et procédé de préparation d'un échantillon pour transplantation de microbiote fécal | |
| EP3573631B1 (fr) | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques | |
| EP3285784B1 (fr) | Procédé de préparation d'un échantillon de microbiote fécal | |
| CA3007289C (fr) | Procede de lyophilisation d'un echantillon de microbiote fecal | |
| EP0680336A1 (fr) | Anticorps monoclonaux anti-lfa-1 pour la preparation d'un medicament destine a prevenir le rejet des greffes d'organes | |
| EP1879655A2 (fr) | Combinaison pharmaceutique comprenant un antibactérien et une substance active choisie parmi le carvéol, le thymol, l'eugénol, le borneol et le carvacrol | |
| CN109628311A (zh) | 用于保护肠道菌的冻干保护剂、冻干粉、胶囊及其制备方法 | |
| JP2011041478A (ja) | パパイヤ発酵食品 | |
| Ikemoto et al. | Donor-specific tolerance induced by simultaneous allogeneic islet transplantation with CD4+ CD25+ T-cells into hepatic parenchyma in mice | |
| EP2217698B1 (fr) | Methode d'optimisation des greffes de cellules sanguines | |
| JP4865838B2 (ja) | プリン体吸収抑制組成物 | |
| EP1881838B1 (en) | Antitumor agent on the base of bcg vaccine, method for its preparation and its use | |
| JP2022543149A (ja) | 自家胸腺組織の移植 | |
| KR20240122658A (ko) | 이식 거부 반응의 예방 또는 치료용 조성물 | |
| WO2025239419A1 (ja) | 人工腸内細菌叢の製造方法 | |
| Sung et al. | Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center | |
| Alvaro et al. | Leak Treatment in Pancreas Transplant: 753 | |
| WO2022195212A1 (fr) | Inhibiteurs glycosidiques de levure | |
| Grochowiecki et al. | The Timing and a Cause of the Graft Pancreatectomy Has an Impact on the Simultaneous Pancreas and Kidney Recipient Survival: 449 | |
| Smail et al. | Predictors of End-Stage Renal Disease in Recipients of Pancreas Transplant Alone: 484 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220307 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 7TH ANNIV.) - STANDARD Year of fee payment: 7 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250123 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250123 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250123 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260121 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260121 |